Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Imexhs.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Dimerix ACTION3 Phase 3 interim trial results are out… and they’re good
Experts
CRITERION: Missed the Pro Medicus boat? These cheaper alternatives scan well
News
Hot Money Monday: Which ASX small caps are riding high on momentum, and which are oversold?
Health & Biotech
ScoPo’s Powerplays: ASX health stocks fall, CSL recovers after sinking on latest Novo Nordisk news
Health & Biotech
ASX Health Stocks: Kazia says goodbye to the ASX; IMEXHS wins $2m contract in Colombia
Tech
The ASX tech stocks set to reap benefits of positive cash flow
Health & Biotech
4D Medical’s technology disrupts century-old procedures AND makes over 90pc profit margin
News
Market Highlights: Last hike? Market hopeful the Fed will pause; and a crackdown on crypto influencers
Health & Biotech
ScoPo’s Powerplays: Health sector rattled but ASX X-ray stocks dance, led by boss PME up 28% since June
Health & Biotech
ASX Tech & Biotech: Island Pharma files investigational application for new Dengue Fever drug
Experts
ScoPo’s Powerplays: ‘Big haircuts’ for ASX health stocks – Morgans reviews quarterly results
News
Rise and Shine: What you need to know before the ASX opens
News
Closing Bell: Volatile? The ASX 200 has criss-crossed its opening level for the 17th time today. (So that’s a yes)
Health & Biotech
ASX Health Stocks: Upcoming clinical trials for these two ASX-listed neuro disease biotechs
Experts
ScoPo’s Powerplays: Who stands out in the enterprise imaging sector?
Tech
ASX Tech Stocks: Stadium software player MSL Solutions (ASX:MSL) jumps 12.5% backed by impressive partnerships
Health & Biotech
